Introduction
A best evidence topic was constructed according to a structured protocol. This is fully described in ICVTS w1x.
Three-part question
In wadult patients undergoing redo surgery for left atrioventricular valve regurgitation after atrioventricular septal defect correctionx is wreplacementx superior to wrepairx in terms of wlong-term event free survivalx?
Clinical scenario
A 32-year-old patient who had complete atrioventricular septal defect (AVSD) repair during infancy is scheduled for surgery for severe regurgitation of the left atrioventricular valve. You are planning to operate on this patient and *Corresponding author. Department of Adult Cardiac surgery, Heart Hospital 'G. Monasterio' Foundation, Via Aurelia Sud, 54100 Massa, Italy. Tel.: q39-0585-493604; fax: q39-0585-493614.
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wondering if a direct replacement of the valve is the best option for this patient or whether repair can offer an advantage and what the technical challenges might be during the operation.
Search strategy
Medline 1950 to August 2010 using PUBMED interface watrioventricular septal defectx AND wadultx AND wreoperationx
Search outcome
One-hundred and nine papers were found using the reported search. From these eight papers were identified providing the best evidence to answer the question. These are presented in Table 1 .
Results
Left atrioventricular valve (LAVV) regurgitation or stenosis are the major determinants of mortality and morbidity late Downloaded from https://academic.oup.com/icvts/article-abstract/12/6/1033/720827 by guest on 21 January 2019 Survival after first 82% at 5, 78% at 10, 75% at reoperation for LAVV 15, and 62% survival at 20 years (Ps0.5)
Type of procedure for Repair vs. Replacement LAVV reoperation -69% vs. 55%, Ps0.20 survival AVSD, atrioventricular septal defect; LV, left ventricle; LVOT, left ventricular outflow tract; ASD, atrial septal defect; VSD, ventricular septal defect; PMK, pacemaker; LAVV, left atrioventricular valve; MVP, mitral valve prosthetic; MVR, mitral valve repair; MR, mitral regurgitation; EDV, end-diastolic volume; PAVSD, partial atrial-ventricular septal defect; CAVSD, complete atrioventricular septal defect; AP, antero-posterior; TEE, transesophageal echocardiography; NYHA, New York Heart Association; GUCH, grown up congenital heart disease; MV, mitral valvulopasty. after complete correction of AVSD and warrants prompt correction in presence of symptoms, arrhythmias, left ventricular enlargement or decrease in global function w2x.
Alexi-Meskishvili et al. w3x presented a series of 28 patients undergoing reoperation for recurrent LAVV regurgitation andyor stenosis. Although the analysis is not age-matched, the study reports that repair should be performed only when no or single LAVV anomalies are found intraoperatively; combinations of LAVV pathologies are a risk factor for recurrent antrioventricular (AV) valve incompetence (eight patients; Ps0.0054) and led to valve replacement in five of those eight patients.
On the contrary, Moran et al. w4x found no LAVV lesion to be associated with risk of valve replacement; they reported similar results either with mitral valve prosthetic (MVP) replacement and mitral valve repair (MVR). In their paper, both groups have similar survival rates and improvement of clinical and functional status, but LAVV repair is associated with a longer 'time-to-ultimate valve replacement', thus avoiding the cumulative risks of anticoagulation-related events; furthermore the valve replacement group is at greater risk of complete heart block after the procedure (37.5%). Increasing use of intraoperative echocardiography is also associated with a better understanding of valve anatomy and more likelihood of valve repair.
A recent analysis of Malhotra et al. w5x confirms that valve replacement has a substantial risk of permanent pacemaker (PMK) implantation (MVP vs. MVR 62.5% vs. 13%; Ps0.005); LAVV repair has been the procedure of choice and, although there is risk of further reoperation, the overall mortality and freedom from reoperation does not vary between the two groups and functional class is far better in the repair group wNew York Heart Association (NYHA) I/II MVP vs. MVR -86.7% vs. 57.1% at follow-upx. Severe LAVV regurgitation and subsequent reoperation with MVR is more likely to occur if the cleft of LAVV is closed as a sole procedure, while the association of cleft closure plus augmentation patch is associated with no need for reoperation (40% vs. 0%, Ps0.02); a delayed operation ()two months) since the regurgitation occurs is also associated with an increased rate of reoperation and likelihood of valve replacement.
Left atrioventricular valve regurgitation can be addressed with repair in a large proportion of patients, as depicted by Birim et al. w6x , regardless of the type of AV canal; their group found no difference in the need for reoperation after primary repair between partial AV canal and complete AV canal; moreover there is no difference in the need for surgical procedure and clinical outcome between these two groups. The Mayo Clinic experience, reported recently by Stulak et al. w 7x, confirms that the ultimate choice of procedure did not affect late survival (Ps0.20) or need for further reoperation (Ps0.76), but the transesophageal echocardiography (TEE) guide in the operating room is mandatory in order to achieve a successful repair. They also found that the survival rate of these patients to be lower than that of the matched age-gender populations; so it is mandatory that grown up congenital heart disease (GUCH) patients must be referred to a specialized center with mixed experience in both adult and congenital heart disease management.
Clinical bottom line
In reintervention for LAVV regurgitation and associated pathologies many concepts must be kept in mind. First, the use of intraoperative TEE is useful to assess the mechanism of disease and serve as a guide for intervention. Secondly, repair should be tried in every case, and not only must the mitral valve cleft be closed, but adjunctive procedures should be necessary (as patch augmentation). Third, the complex mechanism of LAVV regurgitation often leads to suboptimal or failure of the repair; in these cases the valve replacement provides better results; the choice of prosthesis must be addressed on the patient's need, although mechanical valve replacement is more frequent due to the average young age of this patient population. Fourth, if necessary, LAVV replacement is a suitable option and longterm follow-up showed no difference in freedom from reoperation and mortality when compared with LAVV repair. Nevertheless, incidence of early complete heart block and the need for a permanent PMK implantation is more likely to occur. Finally, although mechanical improvement occurs after LAVV repair and replacement, functional recovery and left ventricular function is better in the repair group. Regarding the surgical approach we believe that the right mini-thoracotomic approach is feasible and effective, avoiding risks of re-sternotomy, postoperative bleeding and allows a rapid recover after operation w8, 9x.
